Related Experiment Videos

[Non-ulcer gastrointestinal bleedings]

A V Vorobeĭ, V V Klimovich, D I Karpovich

    Khirurgiia
    |December 21, 2010
    PubMed

    Insights

    This study outlines diagnostic and treatment protocols for non-ulcer gastrointestinal bleeding, focusing on rare causes like celiac artery false aneurysms. Endovascular techniques significantly improve patient outcomes.

    Area of Science:

    • Gastroenterology
    • Vascular Surgery
    • Interventional Radiology

    Background:

    • Non-ulcer gastrointestinal bleeding presents diagnostic and therapeutic challenges.
    • Rare etiologies, such as celiac artery false aneurysms, require specialized management.
    • Effective treatment protocols are crucial for improving patient prognosis.

    Purpose of the Study:

    • To define a diagnostic and treatment protocol for non-ulcer gastrointestinal bleeding.
    • To highlight the management of rare causes, specifically celiac artery false aneurysms.
    • To assess the impact of diagnostic protocols and endovascular techniques on patient outcomes.

    Main Methods:

    • Development of a structured diagnostic algorithm for gastrointestinal bleeding.
    • Implementation of endovascular techniques for managing vascular lesions.
    • Review of patient data to evaluate treatment efficacy.

    Main Results:

    • The defined protocol facilitates accurate diagnosis of gastrointestinal bleeding sources.
    • Endovascular interventions demonstrated significant success in treating celiac artery false aneurysms.
    • Patients treated with the protocol and endovascular techniques showed improved outcomes.

    Conclusions:

    • A standardized diagnostic and treatment protocol is effective for non-ulcer gastrointestinal bleeding.
    • Endovascular approaches offer a minimally invasive and highly effective treatment for celiac artery false aneurysms.
    • This integrated approach dramatically improves the management of complex gastrointestinal bleeding cases.

    Related Concept Videos

    Esophageal Varices-II: Clinical Features and Management01:28

    Esophageal Varices-II: Clinical Features and Management

    Esophageal varices often manifest as gastrointestinal bleeding episodes, presenting symptoms like hematemesis (vomiting of blood), hematochezia (passing fresh blood via the rectum), and melena (black, tarry stools). Other signs can include weight loss, anorexia, abdominal discomfort, jaundice, pruritus, altered mental status, and muscle cramps.
    In the initial assessment, a thorough review of the patient's medical history is vital to identify risk factors such as liver disease, alcohol abuse, or...
    Peptic Ulcer Disease III: Clinical Manifestations and Complications01:25

    Peptic Ulcer Disease III: Clinical Manifestations and Complications

    Duodenal UlcersDuodenal ulcers are the most common form of peptic ulcer disease, presenting with chronic, intermittent epigastric pain. Pain typically appears 2–3 hours after meals, especially when the stomach is empty, often waking patients at night. It is characteristically relieved by food or antacids (“pain–food–relief”). Some patients remain asymptomatic until complications like bleeding or perforation emerge, particularly with NSAID or anticoagulant use.Gastric UlcersGastric ulcers share...
    Inflammatory Bowel Disease I: Ulcerative Colitis01:27

    Inflammatory Bowel Disease I: Ulcerative Colitis

    Introduction
    Inflammatory bowel disease, or IBD, encompasses a group of disorders characterized by chronic inflammation or ulceration of the gastrointestinal tract.
    Risk Factors
    The exact cause of IBD remains unclear, although it is believed to be due to a mix of genetic, environmental, microbial, and immune factors. Genetic factors are significant in determining susceptibility to IBD, with family history being a critical risk factor. Individuals with a first-degree relative who has IBD are at...
    Peptic Ulcer01:27

    Peptic Ulcer

    Peptic ulcers are erosive lesions of the gastric or duodenal lining, most commonly caused by Helicobacter pylori infection. This Gram-negative, helical bacterium has adapted to survive the stomach’s acidic environment by producing urease, which converts urea into ammonia and carbon dioxide. The ammonia neutralizes gastric acid in the bacterium’s immediate environment, allowing colonization of the gastric mucosa. H. pylori attaches to mucus-secreting epithelial cells, penetrates the mucus...
    Peptic Ulcer Disease II: Pathophysiology01:24

    Peptic Ulcer Disease II: Pathophysiology

    Peptic ulcer disease develops when protective mechanisms of the gastrointestinal mucosa are overwhelmed by harmful factors, leading to localized erosions in the stomach or proximal duodenum. The main causes are Helicobacter pylori infection and chronic use of nonsteroidal anti-inflammatory drugs (NSAIDs).Helicobacter pylori–Induced InjuryBacterial Adaptation and Colonization:H. pylori is a spiral, Gram-negative bacterium adapted to the acidic stomach. and transmitted through oral-oral or...
    Peptic Ulcer Disease II: Pathophysiology01:28

    Peptic Ulcer Disease II: Pathophysiology

    Peptic Ulcer Disease (PUD) is characterized by the development of ulcers in the stomach or duodenal mucosa. Its pathophysiology is complex, involving a balance between damaging and protective elements.
    Damaging agents such as Helicobacter pylori, gastric acid, pepsin, and nonsteroidal anti-inflammatory drugs (NSAIDs) can weaken the mucosal defense, allowing hydrogen ions to infiltrate back and harm epithelial cells.